Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.03 USD | -3.33% | -6.02% | +15.34% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 127M |
---|---|---|---|---|---|
Net income 2024 * | -30M | Net income 2025 * | -45M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-4.23
x | P/E ratio 2025 * |
-3.72
x | Employees | 28 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.74% |
Latest transcript on Corvus Pharmaceuticals, Inc.
1 day | -3.33% | ||
1 week | -6.02% | ||
Current month | -6.02% | ||
3 months | -4.25% | ||
6 months | +5.73% | ||
Current year | +15.34% |
Managers | Title | Age | Since |
---|---|---|---|
Richard Miller
CEO | Chief Executive Officer | 73 | 14-01-26 |
Leiv Lea
DFI | Director of Finance/CFO | 70 | 14-01-26 |
James Rosenbaum
CTO | Chief Tech/Sci/R&D Officer | - | 22-07-20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Miller
CEO | Chief Executive Officer | 73 | 14-01-26 |
Ian Clark
BRD | Director/Board Member | 62 | 17-01-02 |
Terry Gould
BRD | Director/Board Member | 67 | 14-10-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 2.03 | -3.33% | 164,972 |
24-06-06 | 2.1 | -5.41% | 154,536 |
24-06-05 | 2.22 | +2.78% | 85,566 |
24-06-04 | 2.16 | -2.26% | 91,965 |
24-06-03 | 2.21 | +2.31% | 154,959 |
Delayed Quote Nasdaq, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.34% | 127M | |
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- CRVS Stock